PLRX
Price
$11.21
Change
-$0.39 (-3.36%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
705.9M
46 days until earnings call
RCKT
Price
$10.30
Change
+$0.09 (+0.88%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
1.09B
48 days until earnings call
Ad is loading...

PLRX vs RCKT

Header iconPLRX vs RCKT Comparison
Open Charts PLRX vs RCKTBanner chart's image
Pliant Therapeutics
Price$11.21
Change-$0.39 (-3.36%)
Volume$20.06K
Capitalization705.9M
Rocket Pharmaceuticals
Price$10.30
Change+$0.09 (+0.88%)
Volume$11.43K
Capitalization1.09B
PLRX vs RCKT Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. RCKT commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Hold and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (PLRX: $11.60 vs. RCKT: $10.21)
Brand notoriety: PLRX and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 76% vs. RCKT: 129%
Market capitalization -- PLRX: $705.9M vs. RCKT: $1.09B
PLRX [@Biotechnology] is valued at $705.9M. RCKT’s [@Biotechnology] market capitalization is $1.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $370.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, RCKT is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • PLRX’s TA Score: 4 bullish, 4 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both PLRX and RCKT are a good buy in the short-term.

Price Growth

PLRX (@Biotechnology) experienced а -8.01% price change this week, while RCKT (@Biotechnology) price change was -13.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

PLRX is expected to report earnings on May 12, 2025.

RCKT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($1.09B) has a higher market cap than PLRX($706M). PLRX YTD gains are higher at: -11.921 vs. RCKT (-18.775). PLRX has higher annual earnings (EBITDA): -197.04M vs. RCKT (-247.25M). PLRX has more cash in the bank: 405M vs. RCKT (236M). RCKT has less debt than PLRX: RCKT (25.6M) vs PLRX (60.2M). PLRX (0) and RCKT (0) have equivalent revenues.
PLRXRCKTPLRX / RCKT
Capitalization706M1.09B65%
EBITDA-197.04M-247.25M80%
Gain YTD-11.921-18.77563%
P/E RatioN/AN/A-
Revenue00-
Total Cash405M236M172%
Total Debt60.2M25.6M235%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXRCKT
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-8.16%
RCKT - PLRX
51%
Loosely correlated
-6.16%
NTLA - PLRX
51%
Loosely correlated
-2.99%
CRSP - PLRX
50%
Loosely correlated
+3.23%
PRME - PLRX
50%
Loosely correlated
+0.35%
TRDA - PLRX
49%
Loosely correlated
+2.37%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with FATE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-6.16%
FATE - RCKT
52%
Loosely correlated
-5.30%
NTLA - RCKT
51%
Loosely correlated
-2.99%
DNLI - RCKT
51%
Loosely correlated
+0.79%
PLRX - RCKT
50%
Loosely correlated
-8.16%
PRME - RCKT
50%
Loosely correlated
+0.35%
More